Trademark: 88239260
Status Date
Monday, February 20, 2023
Filing Date
Friday, December 21, 2018
Published for Opposition
Tuesday, November 19, 2019
Abandoned Date
Monday, February 20, 2023
5 Pharmaceutical and biopharmaceutical agents for the treatment of cancer and rare diseases; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer and rare diseases
42 Pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, and genetic diseases
The mark consists of a design of a central point with three immediate extending lines. The top and left lines branch into two similar lines with rounded circular ends and the right line contains an additional line on one side and a single dot on the other side.
Color is not claimed as a feature of the mark.
Feb 21, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 20, 2023
Abandonment - No Use Statement Filed
Aug 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 4, 2022
Sou Extension 5 Granted
Jul 14, 2022
Sou Extension 5 Filed
Aug 1, 2022
Case Assigned To Intent To Use Paralegal
Jul 14, 2022
Teas Extension Received
Jan 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 13, 2022
Sou Extension 4 Granted
Jan 13, 2022
Sou Extension 4 Filed
Jan 13, 2022
Teas Extension Received
Jul 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2021
Sou Extension 3 Granted
Jul 14, 2021
Sou Extension 3 Filed
Jul 14, 2021
Teas Extension Received
Jan 12, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 8, 2021
Sou Extension 2 Granted
Jan 8, 2021
Sou Extension 2 Filed
Jan 8, 2021
Teas Extension Received
Jul 10, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 8, 2020
Sou Extension 1 Granted
Jul 8, 2020
Sou Extension 1 Filed
Jul 8, 2020
Teas Extension Received
Jan 14, 2020
Noa E-Mailed - Sou Required From Applicant
Nov 19, 2019
Official Gazette Publication Confirmation E-Mailed
Nov 19, 2019
Published For Opposition
Oct 30, 2019
Notification Of Notice Of Publication E-Mailed
Oct 17, 2019
Assigned To Lie
Oct 10, 2019
Approved For Pub - Principal Register
Sep 18, 2019
Teas/Email Correspondence Entered
Sep 18, 2019
Correspondence Received In Law Office
Sep 18, 2019
Teas Response To Office Action Received
Mar 19, 2019
Notification Of Non-Final Action E-Mailed
Mar 19, 2019
Non-Final Action E-Mailed
Mar 19, 2019
Non-Final Action Written
Mar 17, 2019
Assigned To Examiner
Jan 16, 2019
Notice Of Design Search Code E-Mailed
Jan 15, 2019
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
